University of Copenhagen, Department of Pharmacy, Universitetsparken 2, 2100 Copenhagen, Denmark.
Adv Drug Deliv Rev. 2019 Mar 1;142:35-49. doi: 10.1016/j.addr.2019.06.010. Epub 2019 Jun 29.
During the past two decades, a range of in vitro models simulating the digestion processes occurring in the stomach and small intestine have been developed to characterize lipid based drug delivery systems (LbDDSs). This review describes the presently existing range of in vitro digestion models and their use in the field of oral drug delivery. The models are evaluated in terms of their suitability to assess LbDDSs, and their ability to produce in vitro - in vivo correlations (IVIVCs). While the pH-stat lipolysis model is by far the most commonly utilized in vitro digestion model in relation to characterizing LbDDSs, a series of recent studies have shown a lack of IVIVCs limiting its future use. Presently, no single in vitro digestion model exists which is able to predict the in vivo performance of various LbDDSs. However, recent research has shown the potential of combined digestion-permeation models as well as species specific digestion models.
在过去的二十年中,已经开发出了一系列模拟胃和小肠中发生的消化过程的体外模型,以表征基于脂质的药物传递系统(LbDDS)。 本综述描述了目前现有的各种体外消化模型及其在口服药物传递领域的应用。 根据其评估适合评估 LbDDS 的程度及其产生体内外相关性(IVIVC)的能力。 尽管 pH -stat 脂肪酶模型是迄今为止与表征 LbDDS 相关的最常用的体外消化模型,但最近的一系列研究表明,其缺乏 IVIVC 限制了其未来的应用。 目前,不存在能够预测各种 LbDDS 体内性能的单一体外消化模型。 但是,最近的研究表明,联合消化渗透模型以及种特异性消化模型具有潜力。